Introducing Bendavia
Introducing Bendavia

Introducing Bendavia

Kayl/thalyađź’­

63 min•0 play•0 paborito
Knowledge
I-play

Paglalarawan

<div class="blog-info"> <div class="field field-name-field-call-date field-type-datetime field-label-hidden"> <div class="field-items">Join us with Dr. Ben Bronstein and Travis Wilson from Stealth Peptides. Stealth Peptides is a private biotech company responsible for the development of innovative mitochondrial therapeutics, including the investigational new drug "Bendavia." Bendavia has been studied in animals and is currently in Phase 2 studies in patients with cardiovascular and kidney diseases. Bendavia appears to target mitochondria and may preserve cellular ATP levels and prevent pathological reactive oxygen species formation in disease.&nbsp; Please join us to learn more about this exciting new drug and future possibilities for use of Bendavia by children and adults with mitochondrial disease.</div> </div> </div> <div class="field field-name-field-about-speaker field-type-text-long field-label-above"> <h5 class="field-label">About The Speaker</h5> <div class="field-items"> <div class="field-item even"> <p><strong>Travis Wilson</strong> is the president and CEO of Stealth Peptides Incorporated, a clinical stage biopharmaceutical company developing a novel class of mitochondria-targeted peptide therapeutics for treatment of ophthalmic and orphan diseases.&nbsp; Stealth Peptides&rsquo; lead compound in Phase 2 development, Bendavia, maintains mitochondrial bioenergetics including membrane potential and respiration under pathological conditions. &nbsp;Bendavia has been shown to improve cellular ATP levels in disease, and prevent pathological reactive oxygen species (ROS) formation, thereby improving compromised cardiac, renal and skeletal muscle function.</p> <p>Travis also serves as a director on several boards for preclinical and clinical stage companies, providing operational and management oversight to a portfolio of companies developing drugs across a broad spectrum of therapeutic focus, including oncology, cardiology and critical care. &nbsp;Travis is a member of the life science investment tea

Mga Creator

darwin_flow

darwin_flow

Creator